• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK TARGET 360 NANO 2 MM X 3 CM; DEVICE, NEUROVASCULAR EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK TARGET 360 NANO 2 MM X 3 CM; DEVICE, NEUROVASCULAR EMBOLIZATION Back to Search Results
Model Number M0035442030
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Dizziness (2194)
Event Date 05/20/2016
Event Type  Injury  
Manufacturer Narrative
This is the fourth of 5 records.Subject device remains implanted.
 
Event Description
It was reported that approximately 5 month post stent-assisted coil embolization of right internal carotid artery-ophthalmic artery, the patient experienced dizziness that was resolved the same day without residual effect.Mri was done and the patient was referred to follow up at balance center.The physician established that the dizziness was related to the procedure, to the stent, and to coils (subject devices).The patient was assessed neurologically after procedure and at 2 month post-procedure with mrs of 0.At 6 month and 12 month post-procedure, nihss and mrs were 0.
 
Event Description
It was reported that approximately 5 month post stent-assisted coil embolization of right internal carotid artery-ophthalmic artery, the patient experienced dizziness that was resolved the same day without residual effect.Mri was done and the patient was referred to follow up at balance center.The physician established that the dizziness was related to the procedure, to the stent, and to coils (subject devices).The patient was assessed neurologically after procedure and at 2 month post-procedure with mrs of 0.At 6 month and 12 month post-procedure, nihss and mrs were 0.
 
Manufacturer Narrative
Expiration date: added.Manufacturing date: added.The device history record (dhr) review confirms that the device met all material, assembly and performance specifications.The subject device was not returned for analysis; therefore, physical as well as a functional testing could not be performed.However, neurological sequelae such as dizziness is a known risk associated with endovascular procedures and noted as such in the device directions for use (dfu).Therefore, an assignable cause of anticipated procedural complication was assigned to this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TARGET 360 NANO 2 MM X 3 CM
Type of Device
DEVICE, NEUROVASCULAR EMBOLIZATION
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
MDR Report Key7192157
MDR Text Key97280160
Report Number3008881809-2018-00037
Device Sequence Number1
Product Code HCG
UDI-Device Identifier07613252600312
UDI-Public(01)07613252600312(17)180831(10)18554640
Combination Product (y/n)N
PMA/PMN Number
K113412
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 02/23/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/15/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/31/2018
Device Model NumberM0035442030
Device Catalogue NumberM0035442030
Device Lot Number18554640
Was Device Available for Evaluation? No
Date Manufacturer Received01/29/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
4 TARGET COILS (STRYKER)
Patient Outcome(s) Other;
Patient Age69 YR
-
-